Page last updated: 2024-10-30

mesalamine and Cough

mesalamine has been researched along with Cough in 5 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.

Research Excerpts

ExcerptRelevanceReference
"Bronchiectasis was treated with inhaled oral steroids and sputum expectoration while she continued mesalamine and azathioprine for ulcerative colitis."4.12Ulcerative colitis-associated bronchiectasis: A rare extraintestinal manifestation of inflammatory bowel disease: A case report. ( Abbas, A; Alhalabi, M; Ali Deeb, S; Ali, F, 2022)
"Due to the frequency of preceding pulmonary disease and the common temporal dissociation regarding intestinal disease, pulmonary manifestations of inflammatory bowel disease are at high risk of being overlooked."2.46[Pulmonary manifestations of inflammatory bowel disease]. ( Bachmann, O; Länger, F; Rademacher, J, 2010)
"A 16-year-old boy was diagnosed with Crohn's disease."1.42Mesalazine-induced Pleuropericarditis in a Patient with Crohn's Disease. ( Ishihara, S; Kanazawa, T; Kawai, K; Kazama, S; Kiyomatsu, H; Kiyomatsu, T; Nozawa, H; Sunami, E; Tanaka, J; Tanaka, T; Watanabe, T; Yamaguchi, H, 2015)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Alhalabi, M1
Ali Deeb, S1
Ali, F1
Abbas, A1
Fehily, SR1
Partsanis, NM1
Christensen, B1
Kiyomatsu, H1
Kawai, K1
Tanaka, T1
Tanaka, J1
Kiyomatsu, T1
Nozawa, H1
Kanazawa, T1
Kazama, S1
Ishihara, S1
Yamaguchi, H1
Sunami, E1
Watanabe, T1
Bachmann, O1
Länger, F1
Rademacher, J1
Muzzi, A1
Ciani, F1
Bianchini, D1
Festini, G1
Volpe, C1

Reviews

1 review available for mesalamine and Cough

ArticleYear
[Pulmonary manifestations of inflammatory bowel disease].
    Der Internist, 2010, Volume: 51 Suppl 1

    Topics: Antibodies, Monoclonal; Antirheumatic Agents; Bronchoscopy; Chest Pain; Colitis, Ulcerative; Cough;

2010

Other Studies

4 other studies available for mesalamine and Cough

ArticleYear
Ulcerative colitis-associated bronchiectasis: A rare extraintestinal manifestation of inflammatory bowel disease: A case report.
    Medicine, 2022, Aug-26, Volume: 101, Issue:34

    Topics: Adult; Azathioprine; Bronchiectasis; Chronic Disease; Colitis, Ulcerative; Cough; Female; Humans; In

2022
Cough in the Immunosuppressed Patient.
    Gastroenterology, 2019, Volume: 156, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Cough; Female; Humans; Immunoco

2019
Mesalazine-induced Pleuropericarditis in a Patient with Crohn's Disease.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:13

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Cough; Crohn Disease; Fever; Humans; Male; Mesa

2015
Adverse pulmonary effects of mesalamine.
    Chest, 1995, Volume: 108, Issue:4

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Cough; Crohn Disease; Female; Humans;

1995